Literature DB >> 27079594

Optical coherence tomography to monitor vigabatrin toxicity in children.

Catherine Origlieri1, Brooke Geddie2, Bethany Karwoski3, Madison M Berl3, Nancy Elling3, William McClintock3, Janet Alexander4, Marlet Bazemore3, Heather de Beaufort3, Kelly Hutcheson5, Marijean Miller3, Jonathan Taylormoore3, Mohamad S Jaafar3, William Madigan3.   

Abstract

PURPOSE: The antiepileptic drug vigabatrin is known to cause permanent loss of vision. Both visual field testing and electroretinogram are used to detect retinal damage. Adult data on optical coherence tomography (OCT) shows that retinal nerve fiber layer (RNFL) thinning may be an early indicator of vigabatrin-induced retinal toxicity. The purpose of this study was to investigate whether OCT can detect early vigabatrin-induced retinal toxicity in children.
METHODS: Pediatric patients (≤18 years of age) requiring vigabatrin for seizure control who were followed at our institution were invited to participate. Patients were examined according to manufacturer guidelines, with most examinations taking place under general anesthesia. RNFL thickness was measured by OCT (Stratus Model 3000, Zeiss) and compared to total cumulative dose of vigabatrin. In most cases, indirect ophthalmoscopy, fundus photography, and electroretinography were also performed.
RESULTS: OCT and complete dosing data was available for 19 patients. Patients with tuberous sclerosis (TS, n = 12) received higher cumulative doses (mean, 1463 g) than non-TS patients (mean, 351 g, P = 0.044). RNFL thinning was detected in the nasal (P < 0.01), superior (P < 0.01), and inferior (P < 0.05) quadrants in patients with TS, particularly once cumulative dose exceeded 1500 g.
CONCLUSIONS: In our study population of patients with TS, higher cumulative doses of vigabatrin were associated with RNFL thinning in the nasal, superior, and inferior quadrants. These findings were pronounced once cumulative dose exceeded 1500 g. This pattern of RNFL thinning is similar to what has been shown in adult patients taking vigabatrin.
Copyright © 2016 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27079594     DOI: 10.1016/j.jaapos.2015.10.020

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  7 in total

1.  The Topographical Relationship between Visual Field Loss and Peripapillary Retinal Nerve Fibre Layer Thinning Arising from Long-Term Exposure to Vigabatrin.

Authors:  John M Wild; Saleh Aljarudi; Philip E M Smith; Carlo Knupp
Journal:  CNS Drugs       Date:  2019-02       Impact factor: 5.749

2.  Aberrant mTOR signaling and disrupted autophagy: The missing link in potential vigabatrin-associated ocular toxicity?

Authors:  K R Vogel; G R Ainslie; P L Pearl; K M Gibson
Journal:  Clin Pharmacol Ther       Date:  2017-02-07       Impact factor: 6.875

3.  Objective Derivation of the Morphology and Staging of Visual Field Loss Associated with Long-Term Vigabatrin Therapy.

Authors:  John M Wild; Philip E M Smith; Carlo Knupp
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

4.  Transcriptome analysis in mice treated with vigabatrin identifies dysregulation of genes associated with retinal signaling circuitry.

Authors:  Dana Walters; Kara R Vogel; Madalyn Brown; Xutong Shi; Jean-Baptiste Roullet; K Michael Gibson
Journal:  Epilepsy Res       Date:  2020-06-20       Impact factor: 3.045

Review 5.  An Update on the Ophthalmologic Features in the Phakomatoses.

Authors:  Solmaz Abdolrahimzadeh; Andrea Maria Plateroti; Santi Maria Recupero; Alessandro Lambiase
Journal:  J Ophthalmol       Date:  2016-07-17       Impact factor: 1.909

6.  Reliability of Handheld Optical Coherence Tomography in Children Younger Than Three Years of Age Undergoing Vigabatrin Treatment for Childhood Epilepsy.

Authors:  Xiang Ji; Tom Wright; Cynthia VandenHoven; Leslie MacKeen; Michelle McFarlane; Henry Liu; Annie Dupuis; Carol Westall
Journal:  Transl Vis Sci Technol       Date:  2020-02-12       Impact factor: 3.283

7.  Retinal and optic nerve changes in microcephaly: An optical coherence tomography study.

Authors:  Eleni Papageorgiou; Anastasia Pilat; Frank Proudlock; Helena Lee; Ravi Purohit; Viral Sheth; Pradeep Vasudevan; Irene Gottlob
Journal:  Neurology       Date:  2018-07-11       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.